Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee CH, Yogesh Shah A, Rao A, Taylor MH, Di Simone C, Hsieh JJ, Pinto A, Gironés Sarrió R, Lee Cohn A, Asim Bilen M, Gunnestad Ribe S, Krohn Tennøe Ø, Richards D, Sweis RF, Courtright J, Heinrich D, Perini R, Kubiak P, Bock D, Okpara CE, Motzer RJ.
Lee CH, et al. Among authors: richards d.
Eur Urol. 2024 May 21:S0302-2838(24)02345-5. doi: 10.1016/j.eururo.2024.05.003. Online ahead of print.
Eur Urol. 2024.
PMID: 38777648
No abstract available.